Natera, Inc. announced that its ultra-sensitive Signatera Genome assay is now broadly available to physicians in the United States. This launch is supp...
Americordblood is seen as one of Cryo-Cell's top competitors. Americordblood was founded in New York, New York} in 2008. Like Cryo-Cell, Americordblood also works within the Health Care Equipment & Services field. Compared to Cryo-Cell, Americordblood generates $23.4M less revenue.